/
/
/

Asarfi Hospital Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---43%
---154%
--19%40%
10%10%10%14%

Peer Comparison

Symbol
APOLLOHOSP-A
MAXHEALTH-A
ASTERDM-A
FORTIS-A
NH-A
MEDANTA-A
LALPATHLAB-A
KIMS-A
AGARWALEYE-A
VIJAYA-A
ASARFI-M
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
7,810₹113202 Cr54.1840.39207.67₹1942 Cr
853₹84036 Cr57.683.3119.84₹1442 Cr
676₹60058 Cr188.460.316.76₹388 Cr
749.4₹57075 Cr54.473.5320.1₹1042 Cr
1,681₹34466 Cr42.2310.1465.36₹806 Cr
1,282.5₹34447 Cr61.945.9129.85₹556 Cr
1,930.8₹32084 Cr59.2110.1142.51₹505 Cr
694.95₹29768 Cr145.711.0412.74₹241 Cr
468.7₹14956 Cr100.81.4313.88₹133 Cr
1,405.75₹14522 Cr77.455.1627.53₹173 Cr
183₹386 Cr21.672.1714.99₹17 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
₹48 Cr₹45 Cr₹46 Cr₹45 Cr₹36 Cr₹35 Cr₹33 Cr₹31 Cr₹23 Cr₹24 Cr₹20 Cr
₹57 L₹64 L₹1 Cr₹76 L₹1 Cr₹4 Cr₹90 L₹1 Cr₹68 L-₹41 L₹1 Cr
₹48 Cr₹46 Cr₹48 Cr₹46 Cr₹37 Cr₹39 Cr₹34 Cr₹32 Cr₹24 Cr₹24 Cr₹21 Cr
₹41 Cr₹40 Cr₹39 Cr₹39 Cr₹32 Cr₹32 Cr₹29 Cr₹27 Cr₹21 Cr₹24 Cr₹19 Cr
₹10 Cr₹8 Cr₹12 Cr₹10 Cr₹8 Cr₹10 Cr₹8 Cr₹8 Cr₹5 Cr₹4 Cr₹5 Cr
₹1 Cr₹71 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹76 L₹80 L₹76 L₹60 L
₹6 Cr₹5 Cr₹7 Cr₹6 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹1 Cr-₹72 L₹1 Cr
₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹1 Cr-₹21 L-₹5 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024
——
₹20 Cr₹20 Cr
₹61 Cr₹51 Cr
₹61 Cr₹51 Cr
₹81 Cr₹70 Cr
₹34 Cr₹17 Cr
₹3 Cr₹3 Cr
₹11 L₹8 Cr
₹3 Cr₹10 Cr
₹1 Cr₹98 L
₹42 Cr₹39 Cr
——
₹13 Cr₹25 Cr
₹13 Cr₹6 Cr
₹9 Cr₹10 Cr
₹6 Cr₹3 Cr
₹41 Cr₹44 Cr
₹164 Cr₹154 Cr
₹80 L₹80 L
₹49 Cr₹32 Cr
——
₹143 Cr₹123 Cr
₹41 Cr₹30 Cr
₹102 Cr₹94 Cr
₹2 Cr₹0
₹61 L₹14 Cr
₹1 Cr₹1 Cr
₹105 Cr₹108 Cr
——
₹2 Cr₹2 Cr
₹40 Cr₹24 Cr
₹1 Cr₹59 L
₹14 L₹6 L
₹15 Cr₹19 Cr
₹58 Cr₹46 Cr
₹17 Cr₹1 Cr
₹164 Cr₹154 Cr
₹41₹36
₹41₹36

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024
₹14 Cr₹6 Cr
₹12 Cr₹11 Cr
-₹28 Cr₹9 Cr
-₹1 Cr₹26 Cr
-₹4 Cr₹26 Cr
-₹7 Cr-₹63 Cr
₹13 Cr₹36 Cr
₹84 L-₹71 L
₹59 L₹1 Cr
₹1 Cr₹59 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)188.00
Volume (₹)25,000.00
High (₹)190.00
Upper Circuit221.75
Low (₹)182.00
Lower Circuit147.85
Prev Close184.80
52W High (₹)256.95
Price187.95
52W Low (₹)135.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)363.64 Cr
Div. Yield (%)0.00
PE Ratio20.42
Debt to Equity0.60
Price to Book2.01
Book Value41.16
EPS (TTM)9.05
Face Value10.00
ROE (%)13.97

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSP-ANSE
MAXHEALTH-ANSE
ASTERDM-ANSE
FORTIS-ANSE
NH-ANSE
MEDANTA-ANSE
LALPATHLAB-ANSE
KIMS-ANSE
AGARWALEYE-ANSE
VIJAYA-ANSE
ASARFI-MNSE
LTP
1W Low
1W High
Market cap (₹)
7935.55-84.45 (-1.05%)
7690.75
8094.50
1,12,296Cr
856.9-27.1 (-3.07%)
843
894.50
83,023Cr
681.6-18.35 (-2.62%)
674
706.20
58,873Cr
740-45.1 (-5.74%)
738
785.95
56,577Cr
1714.4-5.15 (-0.30%)
1662.85
1735
34,527Cr
1281-32.9 (-2.50%)
1257.05
1321.60
34,407Cr
1885.8-46.8 (-2.42%)
1855.70
2002.85
32,511Cr
690.2-14.6 (-2.07%)
685.60
715
29,188Cr
489.05+11.6 (2.43%)
463.30
490.65
14,838Cr
1388.25-50.5 (-3.51%)
1371.65
1460.10
14,443Cr
187.95-12.7 (-6.33%)
182
200
364Cr

Asarfi Hospital Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹10.02Cr; with other income of ₹56.6Lakh, profit before interest and tax came to ₹6.88Cr. Interest expense was ₹1.17Cr; PBT before exceptional items stood at ₹5.71Cr. Basis: consolidated annual results.

Asarfi Hospital Ltd Quaterly Results Key Takeaways

Asarfi Hospital Ltd reported ₹47.53Cr total income from operations in Jun 2026, softer than ₹45.24Cr in Mar 2026 but higher than ₹35.68Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹10.02Cr; with other income of ₹56.6Lakh, profit before interest and tax came to ₹6.88Cr. Interest expense was ₹1.17Cr, taking profit before tax to ₹5.71Cr. After tax of ₹1.44Cr, profit after tax stood at ₹4.27Cr (vs ₹3.92Cr in Mar 2026 and ₹3.12Cr in Jun 2025).